NCT02492750
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,084 public trials
2,045 recruiting studies
Lymphoproliferative Disorders trial results
NCT01626495
- Conditions
- B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
- Locations
-
- CHOP - http://www.chop.edu/service/oncology/pediatric-cancer-research/cart-19-trial.html Philadelphia, Pennsylvania, United States
Completed
Investigating the Effect of Deep Sea Krill Oil Supplementation in Osteoarthritis of the Knee
NCT03483090
- Conditions
- Arthritis, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- University of the Sunshine Coast Clinical Trials Centre, Morayfield Health Hub Morayfield, Queensland, Australia
- University of the Sunshine Coast Clinical Trials Centre, USC Health Clinics Sippy Downs, Queensland, Australia
- CSIRO Nutrition and Health Research Clinic Adelaide, South Australia, Australia
- Emeritus Research Camberwell, Victoria, Australia
NCT00992446
- Conditions
- Adult Diffuse Large B-Cell Lymphoma, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma, +17 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00211185
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Birmingham Hematology and Oncology Birmingham, Alabama, United States
- Hematology Oncology Associates Phoenix, Arizona, United States
- Stanford Cancer Center Stanford, California, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
Completed
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation
NCT02210065
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
NCT01023308
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Anaheim, California, United States
- Novartis Investigative Site Concord, California, United States
- Novartis Investigative Site Los Angeles, California, United States
Completed
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
NCT02921061
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01307267
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
- Locations
-
- City of Hope Duarte, California, United States
- UC San Diego Moores Cancer Center-Investigational Drug Services La Jolla, California, United States
- UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital) La Jolla, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
NCT02902965
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Fakultní nemocnice Brno Brno, Czechia
- Fakultní nemocnice Hradec Králové Nový Hradec Králové, Czechia
- Fakultní nemocnice Ostrava Ostrava-Poruba, Czechia
- Všeobecná fakultní nemocnice v Praha Prague, Czechia